Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simin Xia

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Immunology|December 20, 2021
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor ActivitiesXiaopei Cui, Huifeng Jia, Hong Xin, et al.
Nucleic Acids Research|October 20, 2021
UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic speciesXun Wang, Yang Li, Mengqi He, et al.
International Journal of Biological Macromolecules|January 23, 2022
Structural and functional insights into a novel pre-clinical-stage antibody targeting IL-17A for treatment of autoimmune diseasesJin-Gen Xu, Huifeng Jia, Shi Chen, et al.
Frontiers in Immunology|January 30, 2026
Enhancing anti-tumor immunity through co-blocking PD-L1 and TIGIT by facilitating tumor-directed responses and additional VEGF inhibitionXi Zhu, Xiaopei Cui, Haijia Yu, et al.
Frontiers in Immunology|November 27, 2024
Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potencyXiaojuan Ma, Shuang Zhang, Xiaochen Ren, et al.
Nature Communications|December 31, 2024
An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor controlJin-Gen Xu, Shi Chen, Yang He, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Immunology|December 20, 2021
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor ActivitiesXiaopei Cui, Huifeng Jia, Hong Xin, et al.
Nucleic Acids Research|October 20, 2021
UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic speciesXun Wang, Yang Li, Mengqi He, et al.
International Journal of Biological Macromolecules|January 23, 2022
Structural and functional insights into a novel pre-clinical-stage antibody targeting IL-17A for treatment of autoimmune diseasesJin-Gen Xu, Huifeng Jia, Shi Chen, et al.
Frontiers in Immunology|January 30, 2026
Enhancing anti-tumor immunity through co-blocking PD-L1 and TIGIT by facilitating tumor-directed responses and additional VEGF inhibitionXi Zhu, Xiaopei Cui, Haijia Yu, et al.
Frontiers in Immunology|November 27, 2024
Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potencyXiaojuan Ma, Shuang Zhang, Xiaochen Ren, et al.
Nature Communications|December 31, 2024
An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor controlJin-Gen Xu, Shi Chen, Yang He, et al.
Pageof 4